» Articles » PMID: 22294560

Outcome After Redo-mitral Valve Replacement in Adult Patients: a 10-year Single-centre Experience

Abstract

The aim of this study was to investigate the overall outcome of adult patients undergoing redo-mitral valve replacement (redo-MVR) at our institution. Forty-nine patients (24 males) underwent redo-MVR with either bioprosthetic (n = 24) or mechanical valves (n = 25) between January 2000 and 2010. Median age of patients was 63 years (range 21-80 years), and the mean additive EuroSCORE was 12 ± 4. Median time to re-operation was 8.2 ± 6.6 years for first time redo-MVR and 6.4 ± 5.6 years for second-time redo-MVR. Indications included prosthetic endocarditis (n = 22), para-prosthetic leak (n = 12), structural valve degeneration (n = 8), prosthetic valve thrombosis (n = 6) and malignancy (n = 1). The mean follow-up was 47.5 ± 37.0 months (range 0.1-112.3 months). In-hospital mortality was 12% (n = 6). Mean hospital stay was 17 ± 11 days (range 8-50 days). Actuarial survival at 1 and 5 years was 81 ± 5% and 72 ± 6%, respectively. Three patients required re-intervention: two for prosthetic valve endocarditis and one for para-prosthetic leak. Multivariate analysis showed that overall survival was associated with the LVEF < 50% (P < 0.001), concomitant AVR (P < 0.001) and urgent surgery (P = 0.03).

Citing Articles

Endo-Aortic Clamp for Minimally Invasive Redo Mitral Valve Surgery: Early Outcome.

Barbero C, Pocar M, Costamagna A, Capozza C, Aloi V, Cura Stura E J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590201 PMC: 11594776. DOI: 10.3390/jcdd11110358.


Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis.

Jobeir B, De Vol A, Alanazi Z, Galzerano D, Jobeir A, Alsanei A J Cardiothorac Surg. 2024; 19(1):581.

PMID: 39354596 PMC: 11445961. DOI: 10.1186/s13019-024-03063-5.


Transcatheter Mitral Valve-in-Valve Implantation Applying a Long Pre-Curved Sheath for Patients with Degenerated Bioprosthetic Mitral Valve.

Liu Y, Zhai M, Xu C, Li L, Mao Y, Ma Y Rev Cardiovasc Med. 2024; 24(2):50.

PMID: 39077402 PMC: 11273136. DOI: 10.31083/j.rcm2402050.


Early and long-term outcomes following redo mitral valve surgery in patients with prior minimally invasive mitral valve surgery.

Schumacher K, Marin Cuartas M, Cuesta M, Noack T, Kiefer P, Leontyev S Interdiscip Cardiovasc Thorac Surg. 2024; 38(3).

PMID: 38498841 PMC: 10973936. DOI: 10.1093/icvts/ivae042.


Cardiac Structural and Functional Remodeling After Transcatheter Mitral Valve in Valve Implantation: Early Changes and Prognostic Significance.

Ayuba G, Meng Z, Baldridge A, Goyal A, Tilkens B, Shrivastav R Struct Heart. 2024; 8(2):100264.

PMID: 38481712 PMC: 10927451. DOI: 10.1016/j.shj.2023.100264.


References
1.
Piehler J, Blackstone E, Bailey K, Sullivan M, Pluth J, Weiss N . Reoperation on prosthetic heart values. Patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg. 1995; 109(1):30-48. DOI: 10.1016/s0022-5223(95)70418-3. View

2.
Akay T, Gultekin B, Ozkan S, Aslim E, Uguz E, Sezgin A . Mitral valve replacements in redo patients with previous mitral valve procedures: mid-term results and risk factors for survival. J Card Surg. 2008; 23(5):415-21. DOI: 10.1111/j.1540-8191.2008.00630.x. View

3.
Maganti M, Rao V, Armstrong S, Feindel C, Scully H, David T . Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009; 87(2):521-5. DOI: 10.1016/j.athoracsur.2008.09.030. View

4.
Jamieson W, Burr L, Miyagishima R, Janusz M, Fradet G, Lichtenstein S . Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation. 2003; 108 Suppl 1:II98-102. DOI: 10.1161/01.cir.0000089184.46999.f4. View

5.
Morishita K, Mawatari T, Baba T, Fukada J, Abe T . Re-replacement for prosthetic valve dysfunction: analysis of long-term results and risk factors. Ann Thorac Surg. 1998; 65(3):696-9. DOI: 10.1016/s0003-4975(97)01426-4. View